This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet βcells in diabetes. J Biol Chem. 2004; 279(41): 42351-42354.RobertsonRPChronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet βcells in diabetesJ Biol Chem200427941423514235410.1074/jbc.R40001920015258147Search in Google Scholar
Hari Kumar KVS, Modi KD. Twins and endocrinology. Indian J Endocrinol Metab. 2014; 18(Suppl 1): S48-S52.Hari KumarKVSModiKDTwins and endocrinologyIndian J Endocrinol Metab201418Suppl 1S48S5210.4103/2230-8210.145074426686825538877Search in Google Scholar
Bramswig NC, Kaestner KH. Epigenetics and diabetes treatment: An unrealized promise? Trends Endocrinol Met. 2012; 23(6): 286-291.BramswigNCKaestnerKHEpigenetics and diabetes treatment: An unrealized promise?Trends Endocrinol Met201223628629110.1016/j.tem.2012.02.002336712122424897Search in Google Scholar
Kommoju U, Reddy BM. Genetic etiology of type 2 diabetes mellitus: A review. Int J Diab Dev Ctries. 2011; 31(2): 51-64.KommojuUReddyBMGenetic etiology of type 2 diabetes mellitus: A reviewInt J Diab Dev Ctries2011312516410.1007/s13410-011-0020-8Search in Google Scholar
Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: Worthless or valuable? [Research Support, Non-U.S. Gov’t Review]. Diabetes Care. 2013; 36(Suppl 2): S120-S126.LyssenkoVLaaksoMGenetic screening for the risk of type 2 diabetes: Worthless or valuable?Research Support, Non-U.S. Gov’t Review]. Diabetes Care201336Suppl 2S120S12610.2337/dcS13-2009392080023882036Search in Google Scholar
Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. [10.1038/ 414782a]. Nature. 2001; 414(6865): 782-787.ZimmetPAlbertiKGMMShawJGlobal and societal implications of the diabetes epidemic. [10.1038/ 414782a]Nature2001414686578278710.1038/414782a11742409Search in Google Scholar
Ling C, Groop L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes. 2009; 58(12): 2718-2725.LingCGroopLEpigenetics: A molecular link between environmental factors and type 2 diabetesDiabetes200958122718272510.2337/db09-1003278086219940235Search in Google Scholar
Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Gene Dev. 2009; 23(7): 781-783.BergerSLKouzaridesTShiekhattarRShilatifardAAn operational definition of epigeneticsGene Dev200923778178310.1101/gad.1787609395999519339683Search in Google Scholar
Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007; 128(4): 669-681.BernsteinBEMeissnerALanderESThe mammalian epigenomeCell2007128466968110.1016/j.cell.2007.01.03317320505Search in Google Scholar
Tsai H-C, Baylin SB. Cancer epigenetics: Linking basic biology to clinical medicine. Cell Res. 2011; 21(3): 502-517.TsaiH-CBaylinSBCancer epigenetics: Linking basic biology to clinical medicineCell Res201121350251710.1038/cr.2011.24319341921321605Search in Google Scholar
Patra SK, Deb M, Patra A. Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin Epigenetics. 2011; 2(1): 27-53.PatraSKDebMPatraAMolecular marks for epigenetic identification of developmental and cancer stem cellsClin Epigenetics201121275310.1007/s13148-010-0016-0336537422704268Search in Google Scholar
Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. [Research Support, Non-U.S. Gov’t Review]. Trends Biochem Sci. 2006; 31(2): 89-97. 10.1016/j.tibs.2005.12.008.KloseRJBirdAPGenomic DNA methylation: the mark and its mediators. [Research Support, Non-U.S. Gov’t Review]Trends Biochem Sci2006312899710.1016/j. tibs.2005.12.00810.1016/j.tibs.2005.12.00816403636Search in Google Scholar
Keating ST, El-Osta A. Epigenetic changes in diabetes. [Research Support, Non-U.S. Gov’t Review]. Clin Genet. 2013; 84(1): 1-10. 10.1111/cge.12121.KeatingSTEl-OstaAEpigenetic changes in diabetes. [Research Support, Non-U.S. Gov’t Review]Clin Genet201384111010.1111/cge.1212110.1111/cge.1212123398084Search in Google Scholar
Bird A. DNAmethylation patterns and epigenetic memory. [Research Support, Non-U.S. Gov’t Review]. Genes Dev. 2002; 16(1): 6-21.BirdADNAmethylation patterns and epigenetic memory. [Research Support, Non-U.S. Gov’t Review]. Genes Dev2002161621Search in Google Scholar
Clouaire T, Stancheva I. Methyl-CpG binding proteins: Specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci. 2008; 65(10): 1509-1522.ClouaireTStanchevaIMethyl-CpG binding proteins: Specialized transcriptional repressors or structural components of chromatin?Cell Mol Life Sci200865101509152210.1007/s00018-008-7324-y287356418322651Search in Google Scholar
Chavali V, Tyagi N, Tyagi SC, Mishra PK. MiR-133 as an epigenetic regulator of diabetic heart failure. FASEB J. 2012; 26(1_MeetingAbstracts): 1057.1022.ChavaliVTyagiNTyagiSCMishraPKMiR-133 as an epigenetic regulator of diabetic heart failureFASEB J2012261_MeetingAbstracts): 1057.102210.1096/fasebj.26.1_supplement.1057.22Search in Google Scholar
Adela R, Banerjee SK. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: A translational prospective. J Diabetes Res. 2015; 2015: 4090842. 101155/2015/490842.AdelaRBanerjeeSKGDF-15 as a target and biomarker for diabetes and cardiovascular diseases: A translational prospectiveJ Diabetes Res201520154090842101155/2015/49084210.1155/2015/490842453025026273671Search in Google Scholar
Lindahl B. The story of growth differentiation factor 15: another piece of the puzzle. Clin Chem. 2013; 59(11): 1550-1552.LindahlBThe story of growth differentiation factor 15: another piece of the puzzle. Clin Chem201359111550155210.1373/clinchem.2013.21281124003064Search in Google Scholar
Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, et al. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fribrilation (ARISTOTLE) trial. Circulation; 2014; 130(21): 1847-1858.WallentinLHijaziZAnderssonUAlexanderJHDe CaterinaRHannaMet alGrowth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fribrilation (ARISTOTLE) trialCirculation2014130211847185810.1161/CIRCULATIONAHA.114.01120425294786Search in Google Scholar
Al-Moghrabi N, NofelA, Al-Yousef N, Madkhali S, Bin Amer SM, Alaiya A, et al. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. [Research Support, Non-U.S. Gov’t]. BMC Cancer. 2014; 14: 830. 10.1186/1471-2407-14-830.Al-MoghrabiNNofelA Al-YousefNMadkhaliSBin AmerSMAlaiyaAet alThe molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. [Research Support, Non-U.S. Gov’t]BMC Cancer20141483010.1186/1471-2407-14-83010.1186/1471-2407-14-830428916725403427Search in Google Scholar
Walker BA, Wardell CP, Chiecchio L, Smith EM, Boyd KD, Neri A, et al. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. Blood. 2011; 117(2): 553-562.WalkerBAWardellCPChiecchioLSmithEMBoydKDNeriAet alAberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]Blood2011117255356210.1182/blood-2010-04-27953920944071Search in Google Scholar
Brevetti G, Schiano V, Chiariello M. Cellular adhesion molecules and peripheral arterial disease. (Review). Vasc Med. 2006; 11(1); 39-47.BrevettiGSchianoVChiarielloMCellular adhesion molecules and peripheral arterial disease. (Review)Vasc Med2006111394710.1191/1358863x06vm645ra16669412Search in Google Scholar
Park JG, Yoo JY, Jeong SJ, Choi JH, Lee MR, Lee MN, et al. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. [Research Support, Non-U.S. Gov’t]. Circ Res. 2011; 109(7): 739-749.ParkJGYooJYJeongSJChoiJHLeeMRLeeMNet alPeroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. [Research Support, Non-U.S. Gov’t]Circ Res2011109773974910.1161/CIRCRESAHA.111.245530547474821835911Search in Google Scholar
Brown CO, Schibler J, Fitzgerald MP, Singh N, Salem K, Zhan F, et al. Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma. Leukemia Res. 2013; 37(8): 963-969.BrownCOSchiblerJFitzgeraldMPSinghNSalemKZhanFet alScavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myelomaLeukemia Res201337896396910.1016/j.leukres.2013.03.004370068223537707Search in Google Scholar
Scoumanne A, Chen X. Protein methylation: A new regulator of the p53 tumor suppressor. Histol Histopathol. 2008; 23(9): 1143-1149.ScoumanneAChenXProtein methylation: A new regulator of the p53 tumor suppressorHistol Histopathol200823911431149Search in Google Scholar
El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006; 4(3): 369-380.El-SeragHBHampelHJavadiFThe association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidenceClin Gastroenterol Hepatol20064336938010.1016/j.cgh.2005.12.00716527702Search in Google Scholar
Friberg E, Orsini N, Mantzoros C, Wolk A. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia. 2007; 50(7): 13651374.FribergEOrsiniNMantzorosCWolkADiabetes mellitus and risk of endometrial cancer: A meta-analysisDiabetologia20075071365137410.1007/s00125-007-0681-517476474Search in Google Scholar
HuxleyR, Ansary-MoghaddamA, Berringtonde Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. (Meta-Analysis). Br J Cancer. 2005; 92(11): 2076-2083.HuxleyRAnsary-MoghaddamABerringtonde GonzalezABarziFWoodwardMType-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. (Meta-Analysis)Br J Cancer200592112076208310.1038/sj.bjc.6602619236179515886696Search in Google Scholar
Larsson S, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: A metaanalysis. Diabetologia. 2006;49(12):2819-2823.LarssonSOrsiniNBrismarKWolkADiabetes mellitus and risk of bladder cancer: A metaanalysisDiabetologia200649122819282310.1007/s00125-006-0468-017021919Search in Google Scholar
Larsson S, Wolk A. Diabetes mellitus and incidence of kidney cancer: A meta-analysis of cohort studies. Diabetologia. 2011; 54(5): 1013-1018.LarssonSWolkADiabetes mellitus and incidence of kidney cancer: A meta-analysis of cohort studiesDiabetologia20115451013101810.1007/s00125-011-2051-621274512Search in Google Scholar
Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: A meta-analysis. J Natl Cancer I. 2005; 97(22): 1679-1687.LarssonSCOrsiniNWolkADiabetes mellitus and risk of colorectal cancer: A meta-analysisJ Natl Cancer I200597221679168710.1093/jnci/dji37516288121Search in Google Scholar
Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: A meta analysis. Int J Cancer. 2007; 121(4): 856-862.LarssonSCMantzorosCSWolkADiabetes mellitus and risk of breast cancer: A meta analysisInt J Cancer2007121485686210.1002/ijc.2271717397032Search in Google Scholar
